These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6902640)

  • 1. Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall.
    Krogstad DJ; Pargwette AR
    Antimicrob Agents Chemother; 1980 Jun; 17(6):965-8. PubMed ID: 6902640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci.
    Moellering RC; Weinberg AN
    J Clin Invest; 1971 Dec; 50(12):2580-4. PubMed ID: 5001959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial tolerance in group C and group G streptococci.
    Rolston KV; Chandrasekar PH; LeFrock JL
    J Antimicrob Chemother; 1984 Apr; 13(4):389-92. PubMed ID: 6563035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro response to bactericidal activity of cell wall-active antibiotics does not support the general opinion that enterococci are naturally tolerant to these antibiotics.
    Fontana R; Grossato A; Ligozzi M; Tonin EA
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1518-22. PubMed ID: 2171422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic-induced lysis of enterococci.
    Storch GA; Krogstad DJ
    J Clin Invest; 1981 Sep; 68(3):639-45. PubMed ID: 6792220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative killing rates of fluoroquinolones and cell wall-active agents.
    Fung-Tomc JC; Gradelski E; Valera L; Kolek B; Bonner DP
    Antimicrob Agents Chemother; 2000 May; 44(5):1377-80. PubMed ID: 10770784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature effects on minimum inhibitory and bactericidal concentrations of cell wall antibiotics in Streptococcus faecalis.
    Hinks ET; Daneo-Moore L; Braverman S
    Antimicrob Agents Chemother; 1977 Aug; 12(2):281-3. PubMed ID: 409344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
    Auckenthaler R; Wilson WR; Wright AJ; Washington JA; Durack DT; Geraci JE
    Antimicrob Agents Chemother; 1982 Sep; 22(3):448-52. PubMed ID: 6958215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The differentiation and sensitivity of enterococci to chemotherapeutics in urinary tract infections].
    Döll W; Bredt W
    Zentralbl Bakteriol Orig; 1968; 209(1):18-25. PubMed ID: 4988771
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.
    Moellering RC; Wennersten C; Weinberg AN
    J Lab Clin Med; 1971 May; 77(5):821-8. PubMed ID: 4997545
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.
    Cercenado E; Díaz MD; Sánchez-Carrillo C; Vicente T; Bernaldo de Quirós JC
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2816-8. PubMed ID: 8593029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the tolerance of pathogenic enterococci and Staphylococcus aureus to cell wall active antibiotics.
    Ladjouzi R; Bizzini A; Lebreton F; Sauvageot N; Rincé A; Benachour A; Hartke A
    J Antimicrob Chemother; 2013 Sep; 68(9):2083-91. PubMed ID: 23649229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
    Gradelski E; Valera L; Kolek B; Bonner D; Fung-Tomc J
    Int J Antimicrob Agents; 2001 Jul; 18(1):43-8. PubMed ID: 11463525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Activity of Plectasin NZ2114 in Combination with Cell Wall Targeting Antibiotics Against VanA-Type Enterococcus faecalis.
    Breidenstein EB; Courvalin P; Meziane-Cherif D
    Microb Drug Resist; 2015 Aug; 21(4):373-9. PubMed ID: 25785733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of the mechanism of action of antimicrobial agents.
    Swenson RM; Sanford JP
    Adv Intern Med; 1970; 16():373-99. PubMed ID: 4916364
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin.
    Shlaes DM; Etter L; Gutmann L
    Antimicrob Agents Chemother; 1991 Apr; 35(4):776-9. PubMed ID: 2069388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.
    Shanson DC; Tadayon M
    J Hosp Infect; 1986 Mar; 7 Suppl A():65-72. PubMed ID: 2871099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disc sentitivity as a diagnostic aid in the identification of group D enterococci.
    Lee WS
    Am J Med Technol; 1972 Dec; 38(12):496-500. PubMed ID: 4490310
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological changes induced by wall inhibitors in pyogenic cocci.
    Bisaillon JG; de Repentigny J; Mathieu LG
    Rev Can Biol; 1973 Jun; 32(2):69-80. PubMed ID: 4619838
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci.
    Watanakunakorn C; Glotzbecker C
    J Med Microbiol; 1977 Feb; 10(1):133-8. PubMed ID: 584243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.